Hydroxyzine: Clinical Trials

2 trials of Hydroxyzine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Hydroxyzine: new trials by email Literature Review of Hydroxyzine trials Research Report on Hydroxyzine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms
Aprepitant 80 mg, Hydroxyzine 25mg, Placebo of Hydroxyzine - Myeloproliferative Disorder, Aquagenic Pruritus
Phase 3CompletedUniversity Hospital, Brest632019-04-162025-12-03
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28

Conditions studied

Anxiety Disorders (1)  ·  Dementia (1)  ·  Depression (1)  ·  Myeloproliferative Disorders (1)  ·  Psychophysiologic Disorders (1)  ·  Schizophrenia (1)

Sponsors

Hannover Medical School (1)  ·  University Hospital, Brest (1)

Countries

France (1)  ·  Germany (1)

Top investigators

Helge Frieling, Prof., MD (1)

Results publications

PMID 34923994

NIH funding

2018 (1)